Correlation Between Immunocore Holdings and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Immunocore Holdings and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunocore Holdings and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunocore Holdings and Edgewise Therapeutics, you can compare the effects of market volatilities on Immunocore Holdings and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunocore Holdings with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunocore Holdings and Edgewise Therapeutics.
Diversification Opportunities for Immunocore Holdings and Edgewise Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Immunocore and Edgewise is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Immunocore Holdings and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Immunocore Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunocore Holdings are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Immunocore Holdings i.e., Immunocore Holdings and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Immunocore Holdings and Edgewise Therapeutics
Given the investment horizon of 90 days Immunocore Holdings is expected to under-perform the Edgewise Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Immunocore Holdings is 2.04 times less risky than Edgewise Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Edgewise Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 678.00 in Edgewise Therapeutics on December 12, 2024 and sell it today you would earn a total of 1,978 from holding Edgewise Therapeutics or generate 291.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunocore Holdings vs. Edgewise Therapeutics
Performance |
| Timeline |
| Immunocore Holdings |
| Edgewise Therapeutics |
Immunocore Holdings and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunocore Holdings and Edgewise Therapeutics
The main advantage of trading using opposite Immunocore Holdings and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunocore Holdings position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Immunocore Holdings vs. Arcellx | ||
| Immunocore Holdings vs. Ventyx Biosciences | ||
| Immunocore Holdings vs. Vaxcyte | ||
| Immunocore Holdings vs. Nuvalent |
| Edgewise Therapeutics vs. Century Therapeutics | ||
| Edgewise Therapeutics vs. C4 Therapeutics | ||
| Edgewise Therapeutics vs. Mineralys Therapeutics, Common | ||
| Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |